Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    19555858 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: AIR001
2 Withdrawn Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Disease
Condition: Pulmonary Hypertension Inclusion Criteria 1.& lt; TAB& gt; Must be Unaffected by a Neurologica
Interventions: Drug: Carvedilol;   Drug: Imatinib
3 Terminated A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: AIR001 (sodium nitrite inhalation solution)

Indicates status has not been verified in more than two years